Avastin sBLA For Metastatic Breast Cancer Gets Advisory Committee Review
This article was originally published in The Pink Sheet Daily
Executive Summary
Genentech reports that FDA has accepted its resubmitted application, which will be reviewed by the Oncologic Drugs Advisory Committee in December.